A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) | MicrobiomeTrials← Back to trialsNCT07595042
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-31Est. Completion: 2029-06-05
Enrollment target: 900 participants Locations- Fundacion Huesped CRS (Site # 31957), Buenos Aires, Argentina
- Vietnam-University of Sydney CRS (Site # 32495), Sydney, Australia
- Gaborone CRS (Site #: 12701), Gaborone, Botswana
- Molepolole CRS (Site # 12702), Gaborone, Botswana
- Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS (Site #: 12101), Rio de Janeiro, Brazil
- Instituto de Pesquisas em AIDS do Rio Grande do Sul - IPARGS CRS (Site # 12201), Rio Grande, Brazil
- GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS (Site #: 31730), Port-au-Prince, Haiti
- Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS (Site #: 30022), Port-au-Prince, Haiti
- Byramjee Jeejeebhoy Government Medical College (BJGMC) CRS (Site #: 31441), Pune, Maharashtra, India
- YRG CARE CRS (Site # 32075), Chennai, India
- Moi University Clinical Research Center (MUCRC) CRS (Site #: 12601), Eldoret, Rift Valley, Kenya
- Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS (Site #: 12501), Kericho, Rift Valley, Kenya
- Malawi CRS (Site #: 12001), Lilongwe, Central Region, Malawi
Other microbiome trials you might be interested in
TuberculosisHIV
The highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globall…
Pune, IndiaEst. completion Mar 31, 2027
TuberculosisTB Infection
A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tubercu…
Jakarta Pusat, IndonesiaEst. completion Jul 2027
Blantyre CRS (Site #: 30301), Blantyre, MalawiNutrición-Mexico CRS (Site #: 32078), Mexico City, MexicoCentro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS (CITBM) - Unidad de Ensayos Clínicos (UNIDEC) (Site # 31970), Callao, PeruBarranco CRS (Site #: 11301), Lima, PeruSan Miguel CRS (Site # 11302), Lima, PeruSocios en Salud Sucursal Peru CRS (Site # 31985), Lima, PeruTB HIV Innovations and Clinical Research Foundation Corp. (Site #: 31981), Dasmariñas, Cavite, PhilippinesKilimanjaro Christian Medical Centre (KCMC) (Site # 5118), Moshi, TanzaniaThai Red Cross AIDS Research Centre (TRC-ARC) CRS (Site #: 31802), Pathum Wan, Bangkok, ThailandSiriraj Hospital, Mahidol University NICHD CRS (Site # 5115), Bangkok, ThailandChiang Mai University HIV Treatment (CMU HIV Treatment) CRS (Site #: 31784), Chiang Mai, ThailandChiangrai Prachanukroh Hospital NICHD CRS (Site # 5116), Chiang Rai, ThailandJoint Clinical Research Centre (JCRC)/Kampala Clinical Research Site (Site #: 12401), Kampala, UgandaMU-JHU Research Collaboration (MUJHU CARE LTD) CRS (Site # 30293), Kampala, UgandaNational Lung Hospital (Site #: 32483), Hanoi, VietnamMilton Park CRS (Site #: 30313), Harare, ZimbabwePhase 3
Recruiting
Non-small Cell Lung Cancer
This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participa…
Bakersfield, United StatesEst. completion Feb 19, 2029